Literature DB >> 35464267

Comment on: "Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial".

Arthur Marichez1, Jean-Philippe Adam1.   

Abstract

Entities:  

Year:  2022        PMID： 35464267      PMCID： PMC9023834          DOI： 10.21037/hbsn-22-25

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.

Authors:  Kim M Olthoff; Laura Kulik; Benjamin Samstein; Mary Kaminski; Michael Abecassis; Jean Emond; Abraham Shaked; Jason D Christie
Journal:  Liver Transpl       Date:  2010-08       Impact factor: 5.799

2.  Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors.

Authors:  Eric Savier; Chetana Lim; Michel Rayar; Francesco Orlando; Karim Boudjema; Kayvan Mohkam; Mickael Lesurtel; Jean Yves Mabrut; Gabriella Pittau; Nassiba Begdadi; Daniel Cherqui; René Adam; Federica Dondero; Ailton Sepulveda; Olivier Soubrane; Petru Bucur; Louise Barbier; Ephrem Salame; Carine Jasseron; Corinne Antoine; Bruno Riou; Olivier Scatton
Journal:  Transplantation       Date:  2020-09       Impact factor: 4.939

3.  A randomized trial of normothermic preservation in liver transplantation.

Authors:  David Nasralla; Constantin C Coussios; Hynek Mergental; M Zeeshan Akhtar; Andrew J Butler; Carlo D L Ceresa; Virginia Chiocchia; Susan J Dutton; Juan Carlos García-Valdecasas; Nigel Heaton; Charles Imber; Wayel Jassem; Ina Jochmans; John Karani; Simon R Knight; Peri Kocabayoglu; Massimo Malagò; Darius Mirza; Peter J Morris; Arvind Pallan; Andreas Paul; Mihai Pavel; M Thamara P R Perera; Jacques Pirenne; Reena Ravikumar; Leslie Russell; Sara Upponi; Chris J E Watson; Annemarie Weissenbacher; Rutger J Ploeg; Peter J Friend
Journal:  Nature       Date:  2018-04-18       Impact factor: 49.962

4.  The TransMedics Organ Care System for the liver receives FDA pre-market approval.

Authors:  Donald D Chang; Jason J Han
Journal:  Artif Organs       Date:  2021-11-21       Impact factor: 3.094

5.  Hypothermic Oxygenated Machine Perfusion (HOPE) Reduces Early Allograft Injury and Improves Post-Transplant Outcomes in Extended Criteria Donation (ECD) Liver Transplantation from Donation After Brain Death (DBD): Results from a Multicenter Randomized Controlled Trial (HOPE ECD-DBD).

Authors:  Zoltan Czigany; Johann Pratschke; Jiří Froněk; Markus Guba; Wenzel Schöning; Dimitri Aristotle Raptis; Joachim Andrassy; Matthijs Kramer; Pavel Strnad; Rene Hany Tolba; Wenjia Liu; Theresa Keller; Hannah Miller; Sandra Pavicevic; Deniz Uluk; Matej Kocik; Isabella Lurje; Christian Trautwein; Arianeb Mehrabi; Irinel Popescu; Florian Wolfgang Rudolf Vondran; Cynthia Ju; Frank Tacke; Ulf Peter Neumann; Georg Lurje
Journal:  Ann Surg       Date:  2021-07-29       Impact factor: 12.969

6.  Pilot, Open, Randomized, Prospective Trial for Normothermic Machine Perfusion Evaluation in Liver Transplantation From Older Donors.

Authors:  Davide Ghinolfi; Erion Rreka; Vincenzo De Tata; Maria Franzini; Daniele Pezzati; Vanna Fierabracci; Matilde Masini; Andrea Cacciatoinsilla; Maria Lucia Bindi; Lorella Marselli; Valentina Mazzotti; Riccardo Morganti; Piero Marchetti; Giandomenico Biancofiore; Daniela Campani; Aldo Paolicchi; Paolo De Simone
Journal:  Liver Transpl       Date:  2019-03       Impact factor: 5.799

7.  Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial.

Authors:  Rianne van Rijn; Ivo J Schurink; Yvonne de Vries; Aad P van den Berg; Miriam Cortes Cerisuelo; Sarwa Darwish Murad; Joris I Erdmann; Nicholas Gilbo; Robbert J de Haas; Nigel Heaton; Bart van Hoek; Volkert A L Huurman; Ina Jochmans; Otto B van Leeuwen; Vincent E de Meijer; Diethard Monbaliu; Wojciech G Polak; Jules J G Slangen; Roberto I Troisi; Aude Vanlander; Jeroen de Jonge; Robert J Porte
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

8.  Severity of early allograft dysfunction following donation after circulatory death liver transplantation: a multicentre study.

Authors:  Kun Wang; Di Lu; Yuhui Liu; Wangyao Li; Li Zhuang; Zhenyu Ma; Qinfen Xie; Binhua Pan; Yichao Wu; Junli Chen; Lidan Lin; Xiaowen Feng; Qiang Wei; Xuyong Wei; Haiyang Xie; Zhengxin Wang; Shusen Zheng; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2021-01       Impact factor: 7.293

9.  Impact of Portable Normothermic Blood-Based Machine Perfusion on Outcomes of Liver Transplant: The OCS Liver PROTECT Randomized Clinical Trial.

Authors:  James F Markmann; Marwan S Abouljoud; R Mark Ghobrial; Chandra S Bhati; Shawn J Pelletier; Amy D Lu; Shane Ottmann; Tarunjeet Klair; Corey Eymard; Garrett R Roll; Joseph Magliocca; Timothy L Pruett; Jorge Reyes; Sylvester M Black; Christopher L Marsh; Gabriel Schnickel; Milan Kinkhabwala; Sander S Florman; Shaheed Merani; Anthony J Demetris; Shoko Kimura; Michael Rizzari; Ashish Saharia; Marlon Levy; Avinash Agarwal; Francisco G Cigarroa; James D Eason; Shareef Syed; W Kenneth Washburn; Justin Parekh; Jang Moon; Alexander Maskin; Heidi Yeh; Parsia A Vagefi; Malcolm P MacConmara
Journal:  JAMA Surg       Date:  2022-03-01       Impact factor: 16.681

10.  Transplantation of discarded livers following viability testing with normothermic machine perfusion.

Authors:  Hynek Mergental; Richard W Laing; Christina Yap; Simon C Afford; Darius F Mirza; Amanda J Kirkham; M Thamara P R Perera; Yuri L Boteon; Joseph Attard; Darren Barton; Stuart Curbishley; Manpreet Wilkhu; Desley A H Neil; Stefan G Hübscher; Paolo Muiesan; John R Isaac; Keith J Roberts; Manuel Abradelo; Andrea Schlegel; James Ferguson; Hentie Cilliers; Julian Bion; David H Adams; Chris Morris; Peter J Friend
Journal:  Nat Commun       Date:  2020-06-16       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.